Ulinastatin - Techpool

Drug Profile

Ulinastatin - Techpool

Alternative Names: Techpool Roan

Latest Information Update: 12 Jan 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Guangdong Techpool Bio-Pharma
  • Class Anti-inflammatories; Cytoprotectives; Glycoproteins; Uroprotectives
  • Mechanism of Action Serine protease inhibitors; Trypsin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Pancreatitis; Vascular disorders
  • Phase I Severe acute respiratory syndrome

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 12 Jan 2016 TechPool and Peking Union Medical College Hospital plans a phase IV trial for Sepsis and Septic shock in China (NCT02647554)
  • 16 Jul 2014 Phase-I clinical trials in Severe acute respiratory syndrome (In volunteers) in China (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top